Ikonisys is a global provider of automated Fluorescence in Situ Hybridization (FISH) technology, microscopes, software, and reagents for genetic analysis and cancer diagnostics. The company serves laboratories, pathologists, and technicians by offering tools to detect genetic abnormalities, analyze rare cells, and monitor treatment responses.
Subscribe to see IKONISYS’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IKONISYS is a healthtech company headquartered in France. Xcout tracks 1 named person at IKONISYS, including Francesco Trisolini (CEO of Hospitex International).
A few of IKONISYS's closest competitors — see the full list of competitors and alternatives →
Ventana Medical Systems, Inc. is a U.S.-based medical technology company that develops automated tissue-diagnostics instruments, reagents, and software for pathology and oncology testing. It serves hospital and clinical laboratories, pathologists, and biomedical researchers, and has been part of Roche since its acquisition in 2008.
Biocare Medical develops and supplies advanced staining instruments, primary antibodies, and detection reagents for immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH). The company serves clinical laboratories, research facilities, and pathologists by providing integrated automated staining platforms and testing solutions.
Lunaphore provides spatial biology products and technologies for research laboratories, including automated tissue analysis instruments like the COMET platform, analysis software such as HORIZON, and detection reagents. These solutions enable researchers to perform multiplex immunohistochemistry and analyze tissue samples with high precision.
Guangzhou LBP Medicine Science & Technology Co., Ltd. specializes in the development and manufacture of innovative pathological diagnostic solutions for the Chinese market. Its comprehensive product portfolio includes advanced pathological diagnostic reagents and essential ancillary equipment. Among these are liquid-based cytology (LBC) offerings, encompassing both gynecological and non-gynecological series, complemented by specialized equipment. The company also provides fluorescence in situ hybridization (FISH) products, which are applied across a broad spectrum of conditions. These applications range from various cancers, including breast, bladder, lung, cervical, prostate, and thyroid, to other complex diagnoses such as neuroblastoma, soft tissue sarcoma, diverse solid tumors, prenatal screening, complications in abortion, oligodendrocytes tumors, lymphoma, multiple myeloma, and several forms of leukemia (chronic myelogenous, chronic lymphocytic, acute myeloid, and acute lymphoblastic), as well as myelodysplastic syndromes. Furthermore, GLBP offers immunohistochemistry (IHC) products, comprising a range of antibodies, advanced detection and repair systems, complementary products, and complete IHC kits. Additionally, its capabilities extend to molecular genetic diagnosis products. Established in 2005, Guangzhou LBP Medicine Science & Technology Co., Ltd. is headquartered in Guangzhou, China.
Immy Inc. develops, manufactures, and distributes diagnostic tests, reagents, and processing systems specializing in mycology. The company serves healthcare professionals, reference laboratories, and hospital settings by providing lateral flow assays, enzyme immunoassays, and PCR tests for the detection of fungal diseases.
Biocare Medical is an IHC primary antibody supplier and manufacturer headquartered in California, United States, with global distribution. The company designs and manufactures advanced staining instruments and reagents as an integrated platform, offering over 300 optimized antibodies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about IKONISYS? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.